SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4rwf'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DB1_A_VDXA428_2 (VITAMIN D NUCLEAR RECEPTOR)	4rwf	ADRENOMEDULLIN MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	LEU A1109 ILE A1120 TYR B 52 VAL A1065	None	0.96A	1db1A-4rwfA: undetectable	1db1A-4rwfA: 17.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E06_A_IPBA600_0 (ODORANT-BINDING PROTEIN)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	VAL A 10 VAL A 52 ILE A 62 ASN A 269	None	0.91A	1e06A-4rwfA: undetectable	1e06A-4rwfA: 12.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MCN_P_DHIP1_0 (IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN) PEPTIDE N-ACETYL-D-HIS-L-PRO -NH2)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	3 / 3	PHE A1111 TYR A2049 PRO A1112	None	1.17A	1mcnA-4rwfA: undetectable 1mcnB-4rwfA: undetectable 1mcnP-4rwfA: undetectable	1mcnA-4rwfA: 16.70 1mcnB-4rwfA: 16.70 1mcnP-4rwfA: 4.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WOP_A_FFOA2887_1 (AMINOMETHYLTRANSFERA SE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	3 / 3	ASP A2090 GLU A2047 ARG A1097	None EDO A2205 ( 3.2A) None	0.79A	1wopA-4rwfA: undetectable	1wopA-4rwfA: 20.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WOP_A_FFOA2888_0 (AMINOMETHYLTRANSFERA SE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 10	LEU A 194 LEU A 197 ILE A 163 GLU A 155 LEU A 153	None None None MAL A2201 (-3.7A) None	1.24A	1wopA-4rwfA: undetectable	1wopA-4rwfA: 20.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F9W_A_PAUA6001_0 (PANTOTHENATE KINASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN ADRENOMEDULLIN (Escherichia coli; Homo sapiens; Homo sapiens)	5 / 11	TYR B 52 ASP A1098 ARG A1097 ILE A2041 ARG A 356	None	1.30A	2f9wA-4rwfB: undetectable 2f9wB-4rwfB: undetectable	2f9wA-4rwfB: 10.05 2f9wB-4rwfB: 10.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F9W_A_PAUA6002_0 (PANTOTHENATE KINASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN ADRENOMEDULLIN (Escherichia coli; Homo sapiens; Homo sapiens)	5 / 8	ARG A 356 TYR B 52 ASP A1098 ARG A1097 ILE A2041	None	1.36A	2f9wA-4rwfA: undetectable 2f9wB-4rwfA: undetectable	2f9wA-4rwfA: 17.98 2f9wB-4rwfA: 17.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	LEU A 264 ILE A 110 VAL A 99 LEU A 78 ILE A 81	None	1.00A	2h42C-4rwfA: undetectable	2h42C-4rwfA: 20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J2P_E_SC2E1289_1 (FICOLIN-2)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	ASP A 199 THR A 195 LYS A 202 ASP A 360	None	1.19A	2j2pE-4rwfA: undetectable 2j2pF-4rwfA: undetectable	2j2pE-4rwfA: 16.02 2j2pF-4rwfA: 16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VE3_A_REAA1445_1 (PUTATIVE CYTOCHROME P450 120)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	ALA A 266 LEU A 282 PHE A 281 VAL A 295 GLY A 18	None None None None EDO A2203 ( 3.9A)	1.08A	2ve3A-4rwfA: undetectable	2ve3A-4rwfA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_B_EV1B1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 8	LEU A 264 ILE A 62 TYR A 72 PHE A 69	None	0.99A	2weyB-4rwfA: 2.1	2weyB-4rwfA: 18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZW9_A_SAMA801_1 (LEUCINE CARBOXYL METHYLTRANSFERASE 2)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 8	THR A 95 LEU A 287 ASP A 289 GLU A 113	None None None MAL A2201 (-3.0A)	1.00A	2zw9A-4rwfA: undetectable	2zw9A-4rwfA: 22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B6H_A_MXDA551_1 (PROSTACYCLIN SYNTHASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	ALA A 190 LEU A 194 ALA A 348 THR A 347	None	0.89A	3b6hA-4rwfA: undetectable	3b6hA-4rwfA: 22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B6H_B_MXDB551_1 (PROSTACYCLIN SYNTHASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	ALA A 190 LEU A 194 ALA A 348 THR A 347	None	0.91A	3b6hB-4rwfA: undetectable	3b6hB-4rwfA: 22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BGD_A_PM6A301_1 (THIOPURINE S-METHYLTRANSFERASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	PHE A 260 ALA A 164 LEU A 249 PRO A 161	None	0.95A	3bgdA-4rwfA: undetectable	3bgdA-4rwfA: 18.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC507_1 (PHOSPHOLIPASE A2)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 7	VAL A 112 GLY A 302 PRO A 231 LYS A 307	None	0.67A	3bjwC-4rwfA: 2.0	3bjwC-4rwfA: 12.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_A_BEZA302_0 (DISULFIDE INTERCHANGE PROTEIN)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	PRO A 128 LEU A 149 ALA A 225 PRO A 127	None	1.30A	3gv1A-4rwfA: undetectable 3gv1C-4rwfA: undetectable	3gv1A-4rwfA: 12.67 3gv1C-4rwfA: 12.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_B_BEZB301_0 (DISULFIDE INTERCHANGE PROTEIN)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	LEU A 149 ALA A 225 PRO A 127 PRO A 128	None	1.28A	3gv1A-4rwfA: undetectable 3gv1B-4rwfA: undetectable	3gv1A-4rwfA: 12.67 3gv1B-4rwfA: 12.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HS6_A_EPAA1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	VAL A 345 GLY A 189 ALA A 190 LEU A 194 LEU A 162	None	1.02A	3hs6A-4rwfA: undetectable	3hs6A-4rwfA: 21.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	10 / 12	ASP A 16 LYS A 17 LYS A 44 GLU A 46 GLU A 47 ALA A 65 ASP A 67 ARG A 68 GLU A 113 TRP A 232	MAL A2201 (-3.0A) MAL A2201 ( 2.7A) None None None MAL A2201 (-3.4A) MAL A2201 (-2.8A) MAL A2201 (-3.8A) MAL A2201 (-3.0A) MAL A2201 ( 4.5A)	0.64A	3jyrA-4rwfA: 61.9	3jyrA-4rwfA: 61.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	10 / 12	ASP A 16 LYS A 17 LYS A 44 GLU A 46 GLU A 47 ALA A 65 ASP A 67 GLU A 113 PRO A 156 TRP A 232	MAL A2201 (-3.0A) MAL A2201 ( 2.7A) None None None MAL A2201 (-3.4A) MAL A2201 (-2.8A) MAL A2201 (-3.0A) MAL A2201 (-3.4A) MAL A2201 ( 4.5A)	0.31A	3jyrA-4rwfA: 61.9	3jyrA-4rwfA: 61.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	6 / 7	ASN A 14 GLU A 155 TYR A 157 MET A 332 TRP A 342 ARG A 346	MAL A2201 (-4.6A) MAL A2201 (-3.7A) MAL A2201 (-3.9A) MAL A2201 ( 4.3A) MAL A2201 (-3.7A) None	0.88A	3jyrA-4rwfA: 61.9	3jyrA-4rwfA: 61.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	6 / 7	ASN A 14 TRP A 64 GLU A 155 TYR A 157 MET A 332 TRP A 342	MAL A2201 (-4.6A) MAL A2201 (-4.3A) MAL A2201 (-3.7A) MAL A2201 (-3.9A) MAL A2201 ( 4.3A) MAL A2201 (-3.7A)	0.17A	3jyrA-4rwfA: 61.9	3jyrA-4rwfA: 61.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP6_B_SALB3004_1 (TRANSCRIPTIONAL REGULATOR TCAR)	4rwf	ADRENOMEDULLIN MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 5	ILE B 47 PHE A2095 ASP A2096 GLU A2099	None	0.71A	3kp6A-4rwfB: undetectable 3kp6B-4rwfB: undetectable	3kp6A-4rwfB: 14.29 3kp6B-4rwfB: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N8Y_B_DIFB585_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	VAL A 198 LEU A 162 GLY A 189 ALA A 190 LEU A 363	None	1.00A	3n8yB-4rwfA: undetectable	3n8yB-4rwfA: 21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	PHE A 158 GLY A 302 LEU A 301 GLU A 113 ALA A 233	None None None MAL A2201 (-3.0A) None	0.86A	3tbgB-4rwfA: undetectable	3tbgB-4rwfA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	PHE A 158 GLY A 302 LEU A 301 GLU A 113 ALA A 233	None None None MAL A2201 (-3.0A) None	0.84A	3tbgD-4rwfA: undetectable	3tbgD-4rwfA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWQ_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	ALA A 233 TYR A 19 TYR A 212 ASN A 236 GLY A 230	None EDO A2203 (-3.4A) None None None	1.34A	3vwqA-4rwfA: undetectable	3vwqA-4rwfA: 20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IIL_A_RBFA401_2 (MEMBRANE LIPOPROTEIN TPN38(B))	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 8	VAL A 112 GLN A 327 ILE A 331 MET A 323	None	1.09A	4iilA-4rwfA: 3.6	4iilA-4rwfA: 20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 5	ASN A 269 ALA A 53 GLY A 58 ASP A 16	None None None MAL A2201 (-3.0A)	0.97A	4n48A-4rwfA: undetectable	4n48A-4rwfA: 20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NTX_A_AMRA509_1 (ACID-SENSING ION CHANNEL 1 BASIC PHOSPHOLIPASE A2 HOMOLOG TX-BETA)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	GLU A 155 GLU A1105 ASN A 351 ARG A 356	MAL A2201 (-3.7A) None None None	1.32A	4ntxA-4rwfA: 2.4 4ntxC-4rwfA: 1.7	4ntxA-4rwfA: 21.96 4ntxC-4rwfA: 10.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O7G_B_ASCB304_0 (PROBABLE TRANSMEMBRANE ASCORBATE FERRIREDUCTASE 2)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	PHE A1121 HIS A1124 ILE A1120 TYR A1093	None	1.48A	4o7gB-4rwfA: undetectable	4o7gB-4rwfA: 16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OKN_B_KANB403_1 (L-LACTATE DEHYDROGENASE A CHAIN)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 9	VAL A 304 TYR A 92 ALA A 314 ARG A 318 ILE A 319	None	1.48A	4oknB-4rwfA: undetectable	4oknB-4rwfA: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OR0_B_NPSB602_1 (SERUM ALBUMIN)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 9	ALA A 266 ALA A 107 LEU A 105 LEU A 264 VAL A 263	None	1.13A	4or0B-4rwfA: undetectable	4or0B-4rwfA: 21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IKT_B_TLFB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN ADRENOMEDULLIN (Escherichia coli; Homo sapiens; Homo sapiens)	3 / 3	TYR A 343 TYR B 52 SER B 45	None	0.85A	5iktB-4rwfA: undetectable	5iktB-4rwfA: 19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_A_RBFA502_1 (RIBOFLAVIN LYASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	6 / 12	ALA A 344 ALA A 340 GLY A 168 ALA A 190 PHE A 171 VAL A 183	None EDO A2204 ( 3.8A) None None None None	1.38A	5w4zA-4rwfA: undetectable	5w4zA-4rwfA: 9.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_B_RBFB502_1 (RIBOFLAVIN LYASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	6 / 12	ALA A 344 ALA A 340 GLY A 168 ALA A 190 PHE A 171 VAL A 183	None EDO A2204 ( 3.8A) None None None None	1.40A	5w4zB-4rwfA: undetectable	5w4zB-4rwfA: 9.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BM5_A_SAMA1301_0 (METHIONINE SYNTHASE)	4rwf	MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN (Escherichia coli; Homo sapiens)	5 / 11	PRO A 135 GLU A 132 PRO A 256 ALA A 165 PRO A 161	None	1.41A	6bm5A-4rwfA: undetectable	6bm5A-4rwfA: 22.01

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DB1_A_VDXA428_2","VITAMIN D NUCLEAR RECEPTOR","4rwf","ADRENOMEDULLIN;MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"LEU A1109;ILE A1120;TYR B  52;VAL A1065","None","0.96A","1db1A-4rwfA:undetectable","1db1A-4rwfA:17.64"],["1E06_A_IPBA600_0","ODORANT-BINDING PROTEIN","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A  10;VAL A  52;ILE A  62;ASN A 269","None","0.91A","1e06A-4rwfA:undetectable","1e06A-4rwfA:12.52"],["1MCN_P_DHIP1_0","IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN);PEPTIDE N-ACETYL-D-HIS-L-PRO-NH2","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",3,"PHE A1111;TYR A2049;PRO A1112","None","1.17A","1mcnA-4rwfA:undetectable;1mcnB-4rwfA:undetectable;1mcnP-4rwfA:undetectable","1mcnA-4rwfA:16.70;1mcnB-4rwfA:16.70;1mcnP-4rwfA:4.65"],["1WOP_A_FFOA2887_1","AMINOMETHYLTRANSFERASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",3,"ASP A2090;GLU A2047;ARG A1097","None;EDO A2205 ( 3.2A);None","0.79A","1wopA-4rwfA:undetectable","1wopA-4rwfA:20.80"],["1WOP_A_FFOA2888_0","AMINOMETHYLTRANSFERASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"LEU A 194;LEU A 197;ILE A 163;GLU A 155;LEU A 153","None;None;None;MAL A2201 (-3.7A);None","1.24A","1wopA-4rwfA:undetectable","1wopA-4rwfA:20.80"],["2F9W_A_PAUA6001_0","PANTOTHENATE KINASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN;ADRENOMEDULLIN","Escherichia coli;Homo sapiens;Homo sapiens",5,"TYR B  52;ASP A1098;ARG A1097;ILE A2041;ARG A 356","None","1.30A","2f9wA-4rwfB:undetectable;2f9wB-4rwfB:undetectable","2f9wA-4rwfB:10.05;2f9wB-4rwfB:10.05"],["2F9W_A_PAUA6002_0","PANTOTHENATE KINASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN;ADRENOMEDULLIN","Escherichia coli;Homo sapiens;Homo sapiens",5,"ARG A 356;TYR B  52;ASP A1098;ARG A1097;ILE A2041","None","1.36A","2f9wA-4rwfA:undetectable;2f9wB-4rwfA:undetectable","2f9wA-4rwfA:17.98;2f9wB-4rwfA:17.98"],["2H42_C_VIAC903_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"LEU A 264;ILE A 110;VAL A  99;LEU A  78;ILE A  81","None","1.00A","2h42C-4rwfA:undetectable","2h42C-4rwfA:20.95"],["2J2P_E_SC2E1289_1","FICOLIN-2;FICOLIN-2","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"ASP A 199;THR A 195;LYS A 202;ASP A 360","None","1.19A","2j2pE-4rwfA:undetectable;2j2pF-4rwfA:undetectable","2j2pE-4rwfA:16.02;2j2pF-4rwfA:16.02"],["2VE3_A_REAA1445_1","PUTATIVE CYTOCHROME P450 120","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"ALA A 266;LEU A 282;PHE A 281;VAL A 295;GLY A  18","None;None;None;None;EDO A2203 ( 3.9A)","1.08A","2ve3A-4rwfA:undetectable","2ve3A-4rwfA:21.50"],["2WEY_B_EV1B1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"LEU A 264;ILE A  62;TYR A  72;PHE A  69","None","0.99A","2weyB-4rwfA:2.1","2weyB-4rwfA:18.92"],["2ZW9_A_SAMA801_1","LEUCINE CARBOXYL METHYLTRANSFERASE 2","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"THR A  95;LEU A 287;ASP A 289;GLU A 113","None;None;None;MAL A2201 (-3.0A)","1.00A","2zw9A-4rwfA:undetectable","2zw9A-4rwfA:22.09"],["3B6H_A_MXDA551_1","PROSTACYCLIN SYNTHASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"ALA A 190;LEU A 194;ALA A 348;THR A 347","None","0.89A","3b6hA-4rwfA:undetectable","3b6hA-4rwfA:22.54"],["3B6H_B_MXDB551_1","PROSTACYCLIN SYNTHASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"ALA A 190;LEU A 194;ALA A 348;THR A 347","None","0.91A","3b6hB-4rwfA:undetectable","3b6hB-4rwfA:22.54"],["3BGD_A_PM6A301_1","THIOPURINE S-METHYLTRANSFERASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"PHE A 260;ALA A 164;LEU A 249;PRO A 161","None","0.95A","3bgdA-4rwfA:undetectable","3bgdA-4rwfA:18.47"],["3BJW_C_SVRC507_1","PHOSPHOLIPASE A2","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 112;GLY A 302;PRO A 231;LYS A 307","None","0.67A","3bjwC-4rwfA:2.0","3bjwC-4rwfA:12.07"],["3GV1_A_BEZA302_0","DISULFIDE INTERCHANGE PROTEIN","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"PRO A 128;LEU A 149;ALA A 225;PRO A 127","None","1.30A","3gv1A-4rwfA:undetectable;3gv1C-4rwfA:undetectable","3gv1A-4rwfA:12.67;3gv1C-4rwfA:12.67"],["3GV1_B_BEZB301_0","DISULFIDE INTERCHANGE PROTEIN","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"LEU A 149;ALA A 225;PRO A 127;PRO A 128","None","1.28A","3gv1A-4rwfA:undetectable;3gv1B-4rwfA:undetectable","3gv1A-4rwfA:12.67;3gv1B-4rwfA:12.67"],["3HS6_A_EPAA1_1","PROSTAGLANDIN G\/H SYNTHASE 2","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"VAL A 345;GLY A 189;ALA A 190;LEU A 194;LEU A 162","None","1.02A","3hs6A-4rwfA:undetectable","3hs6A-4rwfA:21.90"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",10,"ASP A  16;LYS A  17;LYS A  44;GLU A  46;GLU A  47;ALA A  65;ASP A  67;ARG A  68;GLU A 113;TRP A 232","MAL A2201 (-3.0A);MAL A2201 ( 2.7A);None;None;None;MAL A2201 (-3.4A);MAL A2201 (-2.8A);MAL A2201 (-3.8A);MAL A2201 (-3.0A);MAL A2201 ( 4.5A)","0.64A","3jyrA-4rwfA:61.9","3jyrA-4rwfA:61.97"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",10,"ASP A  16;LYS A  17;LYS A  44;GLU A  46;GLU A  47;ALA A  65;ASP A  67;GLU A 113;PRO A 156;TRP A 232","MAL A2201 (-3.0A);MAL A2201 ( 2.7A);None;None;None;MAL A2201 (-3.4A);MAL A2201 (-2.8A);MAL A2201 (-3.0A);MAL A2201 (-3.4A);MAL A2201 ( 4.5A)","0.31A","3jyrA-4rwfA:61.9","3jyrA-4rwfA:61.97"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",6,"ASN A  14;GLU A 155;TYR A 157;MET A 332;TRP A 342;ARG A 346","MAL A2201 (-4.6A);MAL A2201 (-3.7A);MAL A2201 (-3.9A);MAL A2201 ( 4.3A);MAL A2201 (-3.7A);None","0.88A","3jyrA-4rwfA:61.9","3jyrA-4rwfA:61.97"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",6,"ASN A  14;TRP A  64;GLU A 155;TYR A 157;MET A 332;TRP A 342","MAL A2201 (-4.6A);MAL A2201 (-4.3A);MAL A2201 (-3.7A);MAL A2201 (-3.9A);MAL A2201 ( 4.3A);MAL A2201 (-3.7A)","0.17A","3jyrA-4rwfA:61.9","3jyrA-4rwfA:61.97"],["3KP6_B_SALB3004_1","TRANSCRIPTIONAL REGULATOR TCAR;TRANSCRIPTIONAL REGULATOR TCAR","4rwf","ADRENOMEDULLIN;MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"ILE B  47;PHE A2095;ASP A2096;GLU A2099","None","0.71A","3kp6A-4rwfB:undetectable;3kp6B-4rwfB:undetectable","3kp6A-4rwfB:14.29;3kp6B-4rwfB:14.29"],["3N8Y_B_DIFB585_1","PROSTAGLANDIN G\/H SYNTHASE 1","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"VAL A 198;LEU A 162;GLY A 189;ALA A 190;LEU A 363","None","1.00A","3n8yB-4rwfA:undetectable","3n8yB-4rwfA:21.67"],["3TBG_B_RTZB1_1","CYTOCHROME P450 2D6","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"PHE A 158;GLY A 302;LEU A 301;GLU A 113;ALA A 233","None;None;None;MAL A2201 (-3.0A);None","0.86A","3tbgB-4rwfA:undetectable","3tbgB-4rwfA:20.91"],["3TBG_D_RTZD1_1","CYTOCHROME P450 2D6","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"PHE A 158;GLY A 302;LEU A 301;GLU A 113;ALA A 233","None;None;None;MAL A2201 (-3.0A);None","0.84A","3tbgD-4rwfA:undetectable","3tbgD-4rwfA:20.91"],["3VWQ_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"ALA A 233;TYR A  19;TYR A 212;ASN A 236;GLY A 230","None;EDO A2203 (-3.4A);None;None;None","1.34A","3vwqA-4rwfA:undetectable","3vwqA-4rwfA:20.63"],["4IIL_A_RBFA401_2","MEMBRANE LIPOPROTEIN TPN38(B)","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 112;GLN A 327;ILE A 331;MET A 323","None","1.09A","4iilA-4rwfA:3.6","4iilA-4rwfA:20.83"],["4N48_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"ASN A 269;ALA A  53;GLY A  58;ASP A  16","None;None;None;MAL A2201 (-3.0A)","0.97A","4n48A-4rwfA:undetectable","4n48A-4rwfA:20.49"],["4NTX_A_AMRA509_1","ACID-SENSING ION CHANNEL 1;BASIC PHOSPHOLIPASE A2 HOMOLOG TX-BETA","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"GLU A 155;GLU A1105;ASN A 351;ARG A 356","MAL A2201 (-3.7A);None;None;None","1.32A","4ntxA-4rwfA:2.4;4ntxC-4rwfA:1.7","4ntxA-4rwfA:21.96;4ntxC-4rwfA:10.56"],["4O7G_B_ASCB304_0","PROBABLE TRANSMEMBRANE ASCORBATE FERRIREDUCTASE 2","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",4,"PHE A1121;HIS A1124;ILE A1120;TYR A1093","None","1.48A","4o7gB-4rwfA:undetectable","4o7gB-4rwfA:16.58"],["4OKN_B_KANB403_1","L-LACTATE DEHYDROGENASE A CHAIN","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"VAL A 304;TYR A  92;ALA A 314;ARG A 318;ILE A 319","None","1.48A","4oknB-4rwfA:undetectable","4oknB-4rwfA:20.64"],["4OR0_B_NPSB602_1","SERUM ALBUMIN","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"ALA A 266;ALA A 107;LEU A 105;LEU A 264;VAL A 263","None","1.13A","4or0B-4rwfA:undetectable","4or0B-4rwfA:21.91"],["5IKT_B_TLFB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN;ADRENOMEDULLIN","Escherichia coli;Homo sapiens;Homo sapiens",3,"TYR A 343;TYR B  52;SER B  45","None","0.85A","5iktB-4rwfA:undetectable","5iktB-4rwfA:19.82"],["5W4Z_A_RBFA502_1","RIBOFLAVIN LYASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",6,"ALA A 344;ALA A 340;GLY A 168;ALA A 190;PHE A 171;VAL A 183","None;EDO A2204 ( 3.8A);None;None;None;None","1.38A","5w4zA-4rwfA:undetectable","5w4zA-4rwfA:9.43"],["5W4Z_B_RBFB502_1","RIBOFLAVIN LYASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",6,"ALA A 344;ALA A 340;GLY A 168;ALA A 190;PHE A 171;VAL A 183","None;EDO A2204 ( 3.8A);None;None;None;None","1.40A","5w4zB-4rwfA:undetectable","5w4zB-4rwfA:9.43"],["6BM5_A_SAMA1301_0","METHIONINE SYNTHASE","4rwf","MALTOSE TRANSPORTER SUBUNIT, RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR FUSION PROTEIN","Escherichia coli;Homo sapiens",5,"PRO A 135;GLU A 132;PRO A 256;ALA A 165;PRO A 161","None","1.41A","6bm5A-4rwfA:undetectable","6bm5A-4rwfA:22.01"]]